Mcp Al (Metoclopramide Hydrochloride)

Metoclopramide acts on the gastrointestinal motility pathway and the chemoreceptor trigger zone to control emesis and improve gastric emptying.

• Nausea and vomiting: reduces the frequency and severity of acute and chemotherapy‑induced episodes.
• Gastroparesis: enhances gastric emptying and relieves associated symptoms such as early satiety.
• Gastro‑oesophageal reflux disease (GERD): decreases reflux episodes by promoting gastric clearance.

• Metoclopramide antagonizes dopamine D2 receptors in the chemoreceptor trigger zone, which diminishes the vomiting reflex. It also blocks peripheral D2 receptors and stimulates muscarinic receptors, leading to increased acetylcholine release and enhanced gastrointestinal smooth‑muscle contractility, thereby accelerating gastric emptying and improving lower esophageal sphincter tone.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Restlessness: inner sense of agitation or inability to stay still.
• Diarrhea: loose, frequent stools.
• Headache: mild to moderate head pain.
• Dry mouth: reduced salivation.
• Fatigue: general lack of energy.

Serious or Rare Side Effects

• Tardive dyskinesia: involuntary, repetitive movements, especially of the face.
• Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability.
• Severe depression or suicidal thoughts.
• Seizures: convulsive episodes.
• Anaphylaxis: life‑threatening allergic reaction.
• Cardiac arrhythmias: irregular heart rhythms.

Metoclopramide requires careful assessment before and during therapy to minimise risks.

• Renal function: evaluate kidney status and adjust dose if impairment is present.
• Extrapyramidal symptoms: monitor for muscle rigidity, tremor or abnormal movements.
• Lowest effective dose: prescribe the smallest dose needed to achieve therapeutic effect.
• Hypersensitivity: avoid in patients with known allergy to metoclopramide or related compounds.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoclopramide can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid)

• Antipsychotics (e.g., haloperidol): may reduce antiemetic effect and increase extrapyramidal risk.
• Monoamine oxidase inhibitors (MAOIs): can precipitate hypertensive crises.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): raise metoclopramide plasma levels.
• CNS depressants (e.g., opioids, benzodiazepines): enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely)

• Alcohol: may increase drowsiness and dizziness.
• Antihistamines: can potentiate central nervous system effects.
• Selective serotonin reuptake inhibitors (SSRIs): monitor for additive serotonergic activity.
• Antihypertensives: observe for possible blood pressure changes.
• Diabetic agents: watch for altered glucose control.